We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+10.67%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
AUM
$547M
AUM Growth
-$9.74M
Cap. Flow
-$42M
Cap. Flow %
-7.68%
Top 10 Hldgs %
16.06%
Holding
480
New
78
Increased
86
Reduced
74
Closed
239

Top Buys

Rank Stock Value
1
VFC icon
VF Corp
VFC
+$5.76M
2
ACHN
Achillion Pharmaceuticals
ACHN
+$5.22M
3
COR icon
Cencora
COR
+$4.35M
4
NFLX icon
Netflix
NFLX
+$4.25M
5
SBUX icon
Starbucks
SBUX
+$3.8M

Sector Composition

Rank Sector Weight
1 Healthcare 29.46%
2 Technology 20.64%
3 Consumer Discretionary 10.94%
4 Financials 9.21%
5 Industrials 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
101
GSK
GSK
$103B
$1.84M 0.34%
35,424
+9,440
+36% +$532K
ABMD
102
DELISTED
Abiomed Inc
ABMD
$1.84M 0.34%
27,990
+18,540
+196% +$1.23M
XLRN
103
DELISTED
Acceleron Pharma
XLRN
$1.83M 0.33%
+57,740
New +$1.86M
CYBR
104
DELISTED
CyberArk
CYBR
$1.82M 0.33%
+28,970
New +$1.85M
FRSH
105
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$1.79M 0.33%
+86,220
New +$1.58M
OSIR
106
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$1.78M 0.33%
91,500
+90,000
+6,000% +$1.59M
KEY icon
107
KeyCorp
KEY
$24.9B
$1.76M 0.32%
+117,100
New +$1.73M
PCTY icon
108
Paylocity
PCTY
$7.57B
$1.75M 0.32%
+48,960
New +$1.58M
BMY icon
109
Bristol-Myers Squibb
BMY
$134B
$1.72M 0.32%
25,900
+7,240
+39% +$477K
PAYC icon
110
Paycom
PAYC
$7.98B
$1.72M 0.32%
+50,470
New +$1.75M
CSTE icon
111
Caesarstone
CSTE
$79.9M
$1.71M 0.31%
+25,000
New +$1.54M
BOOT icon
112
Boot Barn
BOOT
$4.94B
$1.71M 0.31%
53,390
-15,190
-22% -$397K
HRTX icon
113
Heron Therapeutics
HRTX
$101M
$1.71M 0.31%
54,730
-78,010
-59% -$1.47M
OXM icon
114
Oxford Industries
OXM
$575M
$1.68M 0.31%
19,170
+16,710
+679% +$1.32M
ZBRA icon
115
Zebra Technologies
ZBRA
$17.1B
$1.66M 0.3%
+14,940
New +$1.55M
W icon
116
Wayfair
W
$15.6B
$1.64M 0.3%
43,600
+39,850
+1,063% +$1.29M
WINT
117
DELISTED
Windtree Therapeutics Inc
WINT
$1.56M 0.28%
163,535
-89,448
-35% -$1.26M
HELE icon
118
Helen of Troy
HELE
$666M
$1.55M 0.28%
+15,860
New +$1.4M
CRM icon
119
Salesforce
CRM
$155B
$1.54M 0.28%
22,130
-18,530
-46% -$1.32M
LGIH icon
120
LGI Homes
LGIH
$1.44B
$1.54M 0.28%
77,920
+43,630
+127% +$784K
SNY icon
121
Sanofi
SNY
$103B
$1.54M 0.28%
31,120
-2,090
-6% -$106K
ATHM icon
122
Autohome
ATHM
$2.65B
$1.52M 0.28%
+30,000
New +$1.48M
NVS icon
123
Novartis
NVS
$292B
$1.51M 0.28%
17,108
-6,819
-28% -$626K
EPZM
124
DELISTED
Epizyme, Inc
EPZM
$1.51M 0.28%
+62,790
New +$1.21M
SCAI
125
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$1.46M 0.27%
+38,050
New +$1.44M

Similar funds

Turner Investments's Q2 2015 Portfolio in Review

As of Q2 2015, Turner Investments held 480 positions worth $547M, down 1.8% from $556M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Turner Investments withdrew a net $42M in Q2 2015, closing 239 positions and reducing 74 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $5.47M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Turner Investments opened a new position in VF Corp worth $5.6M.

  • Turner Investments's largest Q2 2015 buy was VF Corp: 85,226 shares worth $5.6M.
  • Turner Investments added most to Cencora in Q2 2015, an estimated $4.35M increase.
  • Turner Investments's biggest Q2 2015 reduction was Ambarella, cutting an estimated $3.62M.
  • Turner Investments fully exited Alexion Pharmaceuticals in Q2 2015, selling an estimated $5.47M.
  • Turner Investments's ten largest holdings make up 16% of its $547M portfolio in Q2 2015.
  • Turner Investments opened 78 new positions and closed 239 in Q2 2015.
  • Turner Investments's portfolio value fell 1.8% quarter-over-quarter to $547M.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.